PMID: 7544395Sep 1, 1995Paper

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

The Journal of Experimental Medicine
B Van den EyndeT Boon

Abstract

Human melanoma MZ2-MEL expresses several distinct antigens that are recognized by autologous cytolytic T lymphocytes (CTL). Some of these antigens are encoded by genes MAGE-1, MAGE-3, and BAGE, which are expressed in a large fraction of tumors of various histological types but are silent in normal adult tissues with the exception of testis. We report here the identification of the gene coding for MZ2-F, another antigen recognized by autologous CTL on MZ2-MEL cells. This gene, which was named GAGE-1, is not related to any presently known gene. It belongs to a family of genes that are expressed in a variety of tumors but not in normal tissues, except for the testis. Antigenic peptide YRPRPRRY, which is encoded by GAGE-1, is recognized by anti-MZ2-F CTL on class I molecule HLA-Cw6. The two genes of the GAGE family that code for this peptide, namely GAGE-1 and GAGE-2, are expressed in a significant proportion of melanomas (24%), sarcomas (25%), non-small cell lung cancers (19%), head and neck tumors (19%), and bladder tumors (12%). About 50% of melanoma patients carry on their tumor at least one of the presently defined antigens encoded by the MAGE, BAGE, and GAGE genes.

References

Mar 1, 1992·The Journal of Experimental Medicine·R GlasH G Ljunggren
Aug 2, 1990·Nature·H G LjunggrenK Kärre
Nov 25, 1990·Nucleic Acids Research·J Girdlestone
Nov 25, 1990·Nucleic Acids Research·M IsamatC Milstein
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B Seed, A Aruffo
Oct 15, 1989·International Journal of Cancer. Journal International Du Cancer·B Van den EyndeT Boon
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·E De PlaenT Boon
Mar 15, 1987·International Journal of Cancer. Journal International Du Cancer·M HérinT Boon
May 1, 1981·Molecular Immunology·S CarrelR S Accolla
Feb 1, 1994·Current Opinion in Immunology·V H Engelhard
Sep 1, 1994·European Journal of Immunology·P van der BruggenT Boon
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·F MuscatelliA P Monaco
Apr 1, 1994·The Journal of Experimental Medicine·H I LevitskyD M Pardoll
Jan 1, 1994·Annual Review of Immunology·T BoonA Van Pel
Mar 1, 1994·The Journal of Experimental Medicine·A B BakkerC G Figdor
Mar 15, 1994·International Journal of Cancer. Journal International Du Cancer·P WeynantsT Boon
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y KawakamiS A Rosenberg
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K FalkH G Rammensee
Jan 1, 1993·Immunogenetics·J Zemmour, P Parham

❮ Previous
Next ❯

Citations

Apr 28, 1999·Journal of Surgical Oncology·M R Hemmila, A E Chang
Jul 17, 1996·International Journal of Cancer. Journal International Du Cancer·G WarnierT Boon
Jul 29, 1996·International Journal of Cancer. Journal International Du Cancer·V RussoC Traversari
Apr 10, 1997·International Journal of Cancer. Journal International Du Cancer·E JägerA Knuth
Nov 5, 1997·International Journal of Cancer. Journal International Du Cancer·A O GureY T Chen
Oct 10, 1998·International Journal of Cancer. Journal International Du Cancer·U SahinM Pfreundschuh
Nov 1, 1996·Seminars in Surgical Oncology·C L Slingluff
Dec 2, 1998·Molecular Carcinogenesis·E R Sauter, M Herlyn
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Nicole J W de WitGoos N P van Muijen
May 7, 2002·International Journal of Cancer. Journal International Du Cancer·Albert J W ZendmanGoos N P Van Muijen
Sep 19, 2002·International Journal of Cancer. Journal International Du Cancer·Angela BarrettJoyce Taylor-Papadimitriou
Nov 15, 2002·International Journal of Cancer. Journal International Du Cancer·Andrés JaramilloThalachallour Mohanakumar
May 15, 2001·International Journal of Cancer. Journal International Du Cancer·A A JungbluthL J Old
Jul 31, 2001·International Journal of Cancer. Journal International Du Cancer·M GriffioenS Osanto
Jan 1, 1996·Springer Seminars in Immunopathology·P Romero
Jan 13, 2001·Diseases of the Colon and Rectum·T SasatomiK Shirouzu
Jan 1, 1997·Immunologic Research·Y Kawakami, S A Rosenberg
May 13, 2008·Pathology Oncology Research : POR·T Schweighoffer
Jan 1, 1996·Immunologic Research·Y Kawakami, S A Rosenberg
Aug 17, 2004·Cancer Immunology, Immunotherapy : CII·Luisa NovellinoGiorgio Parmiani
Jan 13, 2006·Cancer Immunology, Immunotherapy : CII·Amanda K MilesRobert C Rees
Apr 27, 2013·Cancer Immunology, Immunotherapy : CII·Frank NeumannBoris Kubuschok
Dec 1, 2004·Archives of Dermatological Research·Claudia RoederMatthias Lüftl
Sep 17, 2009·General Thoracic and Cardiovascular Surgery·Kosei YasumotoMitsuhiro Takenoyama
Oct 1, 1995·Current Opinion in Immunology·B Van den Eynde, V G Brichard
Dec 1, 1995·Current Opinion in Biotechnology·K Koths
May 15, 2004·Cancer Letters·Axel GerhardtStefan Eichmüller
Nov 20, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H SasakiY Fujii
Dec 16, 2003·Journal of Hepatology·Pablo SarobeIgnacio Melero
Mar 6, 2004·Seminars in Cancer Biology·Vernon K Sondak, Jeffrey A Sosman
Apr 12, 2003·Leukemia Research·Philipp NiemeyerUgur Sahin
Apr 6, 1999·Pharmacology & Therapeutics·B R MinevM S Mitchell
Jan 18, 2003·Biochimica Et Biophysica Acta·Saeyoung ParkDoo-Il Jeoung
Sep 27, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kouhei TajimaTetsuya Mitsudomi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.